Suppression of ERα in luminal MCF-7 breast cancer cells induces EMT and functional properties associated with induced MMPs and uPA/tissue-type plasminogen activator (tPA) concomitant with enhanced EGFR-ERK1/2 signaling [103]. The gene discussed is EGFR; the disease is breast carcinoma.